(Q34434597)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703238%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

review article

1 reference

title

Pharmacological actions and therapeutic uses of cannabis and cannabinoids (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703238%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703238%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

R N Kumar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703238%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

W A Chambers

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703238%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

language of work or name

English

0 references

publication date

1 November 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703238%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703238%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703238%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703238%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

1059-1068

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11703238%20AND%20SRC:MED&resulttype=core&format=json

Adverse effects of cannabis

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Cannabis: pharmacology and toxicology in animals and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Anandamide transport inhibition by the vanilloid agonist olvanil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Cannabinoid receptors and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Spinal cannabinoids are anti-allodynic in rats with persistent inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Two distinctive antinociceptive systems in rats with pathological pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Health consequences of acute and chronic marihuana use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

21 January 2018

Marijuana and immunity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Marijuana smoking and carcinoma of the tongue. Is there an association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Marijuana: harder than thought?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Psychotic reactions following cannabis use in East Indians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Tetrahydrocannabinol for tremor in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Nabilone in the treatment of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

The perceived effects of marijuana on spinal cord injured males

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Marijuana for parkinsonian tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Analgesic Effect of Delta‐9‐Tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

The analgesic properties of delta-9-tetrahydrocannabinol and codeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Pain relief with oral cannabinoids in familial Mediterranean fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Effect of marihuana on intraocular and blood pressure in glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Preoperative marijuana inhalation--an airway concern.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X

Neuropharmacology and therapeutic potential of cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2044.2001.02269.X